Open Access<p>Case Report on Patients with Steinert Disease Complicated by COVID-19</p>
Author(s) -
Roberto Chalela,
Oswaldo Caguana,
Flavio Zuccarino,
Karys Khilzi,
Diego A. Rodríguez-Chiaradía
Publication year - 2020
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s266659
Subject(s) - medicine , pulmonary embolism , covid-19 , pneumonia , disease , cardiology , syncope (phonology) , lung , emergency department , intensive care medicine , infectious disease (medical specialty) , psychiatry
SARS-CoV-2 infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with SARS-CoV-2 infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors.